company background image
CLAI logo

Cel AI LSE:CLAI Stock Report

Last Price

UK£0.0022

Market Cap

UK£1.4m

7D

-21.1%

1Y

-71.0%

Updated

27 Mar, 2024

Data

Company Financials

CLAI Stock Overview

Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom.

CLAI fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Cel AI PLC Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Cel AI
Historical stock prices
Current Share PriceUK£0.0022
52 Week HighUK£0.02
52 Week LowUK£0.002
Beta-1.39
1 Month Change-52.63%
3 Month Change-30.77%
1 Year Change-70.97%
3 Year Change-97.64%
5 Year Changen/a
Change since IPO-98.82%

Recent News & Updates

Recent updates

We're Hopeful That Cellular Goods (LON:CBX) Will Use Its Cash Wisely

Feb 21
We're Hopeful That Cellular Goods (LON:CBX) Will Use Its Cash Wisely

Shareholder Returns

CLAIGB Personal ProductsGB Market
7D-21.1%2.7%2.3%
1Y-71.0%-4.2%2.7%

Return vs Industry: CLAI underperformed the UK Personal Products industry which returned -4.4% over the past year.

Return vs Market: CLAI underperformed the UK Market which returned 3.7% over the past year.

Price Volatility

Is CLAI's price volatile compared to industry and market?
CLAI volatility
CLAI Average Weekly Movement21.2%
Personal Products Industry Average Movement5.5%
Market Average Movement4.8%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.5%

Stable Share Price: CLAI's share price has been volatile over the past 3 months.

Volatility Over Time: CLAI's weekly volatility (21%) has been stable over the past year, but is still higher than 75% of UK stocks.

About the Company

FoundedEmployeesCEOWebsite
20185n/ahttps://www.getcel.ai

Cel AI PLC, together with its subsidiaries, engages in the manufacture and sale of biosynthetic cannabinoids-based consumer products in the United Kingdom. The company provides cannabinoid solutions for skincare and ingestible products. It offers its products through retailers; direct to consumers through its website; and online.

Cel AI PLC Fundamentals Summary

How do Cel AI's earnings and revenue compare to its market cap?
CLAI fundamental statistics
Market capUK£1.36m
Earnings (TTM)-UK£3.31m
Revenue (TTM)UK£67.24k

20.2x

P/S Ratio

-0.4x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CLAI income statement (TTM)
RevenueUK£67.24k
Cost of RevenueUK£25.80k
Gross ProfitUK£41.44k
Other ExpensesUK£3.35m
Earnings-UK£3.31m

Last Reported Earnings

Aug 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.0055
Gross Margin61.63%
Net Profit Margin-4,922.54%
Debt/Equity Ratio0%

How did CLAI perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.